abstract |
The present invention relates to compositions comprising Wnt antagonists and methods of treating diseases and disorders associated with Wnt, such as cancer, that induce differentiation, and reduce the frequency of cancer stem cells, as well as novel methods of analysis to detect Wnt antagonists. In particular, the invention describes soluble FZD, SFRP and Ror receptors and their use. |